Literature DB >> 29305180

Epidemic spreading dynamics with drug resistance and heterogeneous contacts.

Peng-Bi Cui1, Lei Gao1, Wei Wang2.   

Abstract

Drug resistance and strong contacts actually play crucial roles in epidemic spread in complex systems. Nevertheless, neither theoretical model or methodology is proposed to address this. We thus consider an edge-based epidemic spread model considering the two key ingredients, in which the contacts are grouped into two classes: strong contacts and normal ones. Next, we present a unified edge-based compartmental approach to the spread dynamics on Erdös-Rényi (ER) networks and validate its results by extensive numerical simulations. In case that epidemic is totally drug-resistant, we both numerically and theoretically show a continuous growth of epidemics with infection probability when number of strong contacts is not enough for the emergence of null threshold. If the epidemic owns partial resistance, we would observe evident discontinuous growth with infection probability (discontinuous transitions) and larger final epidemic sizes for few strong contacts, instead of emergence of null threshold with increase of strong contacts. Inhibiting effect of infection threshold, positive roles of strong contacts and strength of strong contacts in promoting outbreaks are also approved. Throughout this paper, we could drive exact predictions through the analytical approach, showing good agreements with numerical simulations.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug resistance; Edge-based compartmental theory; Epidemiology; Network dynamics

Mesh:

Year:  2018        PMID: 29305180     DOI: 10.1016/j.jtbi.2018.01.003

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  1 in total

1.  Matrix-Based Formulation of Heterogeneous Individual-Based Models of Infectious Diseases: Using SARS Epidemic as a Case Study.

Authors:  Wei Duan
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.